HAEMONETICS CORP - Director's Dealing 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2020-04-09

Reporting Person: KROLL MARK W (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-31	Common Stock	G	870	—	Disposed	22747	Direct
2020-04-09	Common Stock	M	6573	$45.45	Acquired	29320	Direct
2020-04-09	Common Stock	S	6573	$102.00	Disposed	22747	Direct
2020-04-09	Common Stock	S	4329	$102.00	Disposed	18418	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-09	Non-qualified Stock Option (Right to Buy)	$45.45	M	6573	Disposed	2020-07-24	Common Stock (6573)	Direct

F1: Shares transferred as a bona fide gift without any consideration.

F2: This number includes unvested restricted stock units previously reported.

F3: Transaction pursuant to an existing 10b5-1 trading plan.

F4: Option vests 100% on the first anniversary of the date of grant.